Total Payments
$117,601
2024 Payments
$69,607
Companies
8
Transactions
195
Medicare Patients
7,147
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$106,005 (90.1%)
Food & Beverage$6,250 (5.3%)
Travel$5,346 (4.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $106,005 | 78 | 90.1% |
| Food and Beverage | $6,250 | 80 | 5.3% |
| Travel and Lodging | $5,346 | 37 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $69,587 | 101 | $0 (2024) |
| Allergan, Inc. | $47,536 | 80 | $0 (2020) |
| BOSTON SCIENTIFIC CORPORATION | $309.25 | 4 | $0 (2017) |
| Cumberland Pharmaceuticals, Inc. | $71.69 | 5 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $42.07 | 2 | $0 (2018) |
| Braintree Laboratories, Inc. | $21.42 | 1 | $0 (2023) |
| ABBVIE INC. | $20.00 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $13.39 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $69,607 | 102 | Phathom Pharmaceuticals, Inc. ($69,587) |
| 2023 | $21.42 | 1 | Braintree Laboratories, Inc. ($21.42) |
| 2022 | $13.39 | 1 | Janssen Biotech, Inc. ($13.39) |
| 2021 | $16.67 | 1 | Cumberland Pharmaceuticals, Inc. ($16.67) |
| 2020 | $1,248 | 4 | Allergan, Inc. ($1,217) |
| 2019 | $10,862 | 22 | Allergan Inc. ($10,848) |
| 2018 | $11,569 | 19 | Allergan Inc. ($11,516) |
| 2017 | $24,264 | 45 | Allergan Inc. ($23,954) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $122.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $68.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $33.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $223.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $34.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $54.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $117.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $55.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $47.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $35.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $517.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $346.09 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,898 | 3,551 | $1.9M | $306,059 |
| 2022 | 24 | 1,876 | 3,382 | $1.7M | $301,590 |
| 2021 | 22 | 1,819 | 3,567 | $1.4M | $310,479 |
| 2020 | 20 | 1,554 | 2,836 | $953,018 | $241,344 |
Total Patients
7,147
Total Services
13,336
Medicare Billing
$1.2M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 250 | 1,431 | $346,630 | $102,666 | 29.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 200 | 229 | $83,140 | $35,030 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 375 | $75,140 | $29,519 | 39.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 82 | 85 | $417,200 | $20,802 | 5.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 194 | 207 | $256,800 | $20,085 | 7.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 128 | 128 | $35,980 | $17,853 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 165 | $39,720 | $17,514 | 44.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 142 | 144 | $359,700 | $16,251 | 4.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 91 | 272 | $43,600 | $12,539 | 28.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 77 | 82 | $23,100 | $9,491 | 41.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 34 | 37 | $21,150 | $5,245 | 24.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 56 | 56 | $13,500 | $4,819 | 35.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 18 | $45,000 | $3,248 | 7.2% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 14 | 15 | $7,645 | $2,859 | 37.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 51 | 57 | $9,160 | $2,818 | 30.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 24 | 25 | $30,000 | $2,278 | 7.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 109 | 153 | $3,825 | $1,285 | 33.6% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 11 | 11 | $1,938 | $1,222 | 63.1% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 18 | 21 | $52,500 | $298.89 | 0.6% |
| 82948 | Blood glucose (sugar) measurement using reagent strip | Office | 2023 | 23 | 26 | $650.00 | $128.44 | 19.8% |
| 83014 | Administration of drug for helicobacter pylori | Office | 2023 | 11 | 14 | $280.00 | $107.80 | 38.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 274 | 1,445 | $351,780 | $96,379 | 27.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 206 | 224 | $81,180 | $41,760 | 51.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 185 | 292 | $58,650 | $24,269 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 172 | $41,460 | $19,640 | 47.4% |
About Dr. Jack Braha, DO
Dr. Jack Braha, DO is a Gastroenterology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548456890.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Braha, DO has received a total of $117,601 in payments from pharmaceutical and medical device companies, with $69,607 received in 2024. These payments were reported across 195 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($106,005).
As a Medicare-enrolled provider, Braha has provided services to 7,147 Medicare beneficiaries, totaling 13,336 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Brooklyn, NY
- Active Since 09/20/2007
- Last Updated 03/26/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548456890
Products in Payments
- VOQUEZNA (Drug) $69,587
- LINZESS (Drug) $40,929
- VIBERZI (Drug) $6,601
- WATCHMAN (Device) $158.70
- RESOLUTION CLIP (Device) $134.48
- Entyvio (Biological) $42.07
- Omeclamox (Drug) $24.44
- SUTAB (Drug) $21.42
- CREON (Drug) $20.00
- KRISTALOSE (Drug) $16.67
- Kristalose (Drug) $16.67
- GENERAL - BILIARY DEVICES (Device) $16.07
- Omeclamox-Pak (Drug) $13.91
- STELARA (Biological) $13.39
- ZENPEP (Drug) $6.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Brooklyn
Sam Moskowitz, Md, MD
Gastroenterology — Payments: $349,162
Gastroenterology $349,162
Jianjun Li, M.d, M.D
Gastroenterology — Payments: $307,830
Gastroenterology $307,830
Dr. Nison Badalov, M.d, M.D
Gastroenterology — Payments: $237,374
Gastroenterology $237,374
Smruti Mohanty, Md, Ms, MD, MS
Gastroenterology — Payments: $219,216
Gastroenterology $219,216
Dr. Jonathan Erber, Md, MD
Gastroenterology — Payments: $208,708
Gastroenterology $208,708
Dr. Rabin Rahmani, M.d, M.D
Gastroenterology — Payments: $204,380
Gastroenterology $204,380